Nature Immunology, Published online: 17 August 2026; doi:10.1038/s41590-026-02625-0 Notch2 deletion in dendritic cells (DCs), already known to impair type 2a DC development and intestinal immunity, is now demonstrated to promote dysbiosis and unleash inflammatory AXL-expressing type 3 DCs, driving preclinical autoimmunity.